Eligi
Med
Base de datos
Seguridad
Sobre EligiMed
Contacto
Contáctenos
Ensayos Clínicos | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Open-Label, Parallel-Group Study to Evaluate the Efficacy of Preprandial Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Patients With Type 1 Diabetes Mellitus
INTERVENTIONAL
Inicio: 1 de ago de 2006
ID: NCT00356109
Completado
Fase 3
ClinicalTrials.gov
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro With an Open-Label Postprandial LY900014 Treatment Group, in Combination With Insulin Glargine or Insulin Degludec, in Adults With Type 1 Diabetes PRONTO-T1D
INTERVENTIONAL
Inicio: 17 de jul de 2017
ID: NCT03214367
Terminado
Fase 3
ClinicalTrials.gov
ARTEMIS-IPF: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel-Group, Event Driven Study to Evaluate the Efficacy and Safety of Ambrisentan in Subjects With Early Idiopathic Pulmonary Fibrosis (IPF)
INTERVENTIONAL
Inicio: 1 de dic de 2008
ID: NCT00768300
Completado
Fase 3
ClinicalTrials.gov
A Randomized Phase III Study Comparing Upfront Debulking Surgery Versus Neo-Adjuvant Chemotherapy in Patients With Stage IIIC or IV Epithelial Ovarian Carcinoma
INTERVENTIONAL
Inicio: 1 de sept de 1998
ID: NCT00003636
Terminado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety, and Tolerability of Dexpramipexole Administered Orally for 52 Weeks in Participants With Severe Eosinophilic Asthma
INTERVENTIONAL
Inicio: 30 de ene de 2023
ID: NCT05763121
Completado
Fase 3
ClinicalTrials.gov
A Phase 3 Randomized, Double-Blind Study of Nivolumab Monotherapy or Nivolumab Combined With Ipilimumab vs Placebo in Participants With Localized Renal Cell Carcinoma Who Underwent Radical or Partial Nephrectomy and Who Are at High Risk of Relapse
INTERVENTIONAL
Inicio: 7 de jul de 2017
ID: NCT03138512
Desconocido
ClinicalTrials.gov
Multicentre, Open Label, Extension Study of Treatment With Gefitinib(IRESSA™) for Patients Completing Other Gefitinib Clinical Studies Who May Benefit From Gefitinib Treatment
EXPANDED_ACCESS
ID: NCT00683306
Completado
ClinicalTrials.gov
Analysis of the Effect of Acidified Omega 3 Esters (DHA+EPA) in Hypertensive Patients With Increased Triglycerides
INTERVENTIONAL
Inicio: 23 de mar de 2023
ID: NCT06840964
Completado
Fase 3
ClinicalTrials.gov
A Phase 3 Randomized, Double-blind, Active-controlled, Parallel-group, Multi-center Study in Hemodialysis Participants With Anemia of Chronic Kidney Disease to Evaluate the Efficacy, Safety and Pharmacokinetics of Three-times Weekly Dosing of Daprodustat Compared to Recombinant Human Erythropoietin, Following a Switch From Recombinant Human Erythropoietin or Its Analogs
INTERVENTIONAL
Inicio: 5 de sept de 2018
ID: NCT03400033
Completado
ClinicalTrials.gov
Registry to Improve the Adoption of Consensus Treatment Guidelines (IMPROVE Brady)
OBSERVATIONAL
Inicio: 1 de jul de 2012
ID: NCT01643707
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Open-Label, Phase 3 Trial of Tisotumab Vedotin vs Investigator's Choice Chemotherapy in Second- or Third-Line Recurrent or Metastatic Cervical Cancer
INTERVENTIONAL
Inicio: 22 de feb de 2021
ID: NCT04697628
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, International Randomized, 2x2 Factorial Design Study to Evaluate the Effects of Lantus (Insulin Glargine) Versus Standard Care, and of Omega-3 Fatty Acids Versus Placebo, in Reducing Cardiovascular Morbidity and Mortality in High Risk People With Impaired Fasting Glucose (IFG), Impaired Glucose Tolerance (IGT) or Early Type 2 Diabetes Mellitus: The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention)
INTERVENTIONAL
Inicio: 1 de ago de 2003
ID: NCT00069784
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction (PARAGON-HF)
INTERVENTIONAL
Inicio: 18 de jul de 2014
ID: NCT01920711
Terminado
Fase 3
ClinicalTrials.gov
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
INTERVENTIONAL
Inicio: 1 de dic de 2010
ID: NCT01127633
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Favipiravir in Adult Subjects With Uncomplicated Influenza
INTERVENTIONAL
Inicio: 1 de dic de 2013
ID: NCT02008344
Completado
ClinicalTrials.gov
Characteristics and Management of Acute Kidney Injury in Hospitalized Patients With Cirrhosis: a Multicenter Intercontinental Observational Prospective Study: The International Club of Ascites GLOBAL AKI Project
OBSERVATIONAL
Inicio: 1 de jul de 2022
ID: NCT05387811
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled, Multicenter, Two-part, Dose Ranging and Confirmatory Study With an Operationally Seamless Design, Evaluating Efficacy and Safety of SAR153191 on Top of Methotrexate (MTX) in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MTX Therapy
INTERVENTIONAL
Inicio: 1 de mar de 2010
ID: NCT01061736
Completado
Fase 3
ClinicalTrials.gov
A Randomized Three-Arm, Multicenter Comparison of 1 Year and 2 Years of Herceptin Versus No Herceptin in Women With HER2-Positive Primary Breast Cancer Who Have Completed Adjuvant Chemotherapy
INTERVENTIONAL
Inicio: 1 de nov de 2001
ID: NCT00045032
Completado
ClinicalTrials.gov
Accuracy in the Evaluation of Brain Response to Mechanical and Radiofrequency Stimuli in Humans
INTERVENTIONAL
Inicio: 11 de mar de 2024
ID: NCT06183593
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Comparative Trial Of A Novel CCR5 Antagonist, UK-427,857, In Combination With Zidovudine/Lamivudine Versus Efavirenz In Combination With Zidovudine/Lamivudine For The Treatment Of Antiretroviral-Naive HIV-1 Infected Subjects
INTERVENTIONAL
Inicio: 1 de nov de 2004
ID: NCT00098293
Anterior
1
...
417
418
419
...
434
Siguiente
Filtros